Calamos High Income Opportunities I holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
Calamos High Income Opportunities Fund Class I CIHYX
- NAV / 1-Day Return 7.76 / −0.13 %
- Total Assets 22.4M
-
Adj. Expense Ratio
0.750%
- Expense Ratio 0.750%
- Distribution Fee Level Above Average
- Share Class Type Institutional
- Category High Yield Bond
- Credit Quality / Interest Rate Sensitivity Low/Limited
- Min. Initial Investment 1M
- Status Open
- TTM Yield 6.34%
- Effective Duration 2.67 years
USD | NAV as of Jun 18, 2026 | 1-Day Return as of Jun 18, 2026, 12:11 AM GMT+0
Morningstar’s Analysis CIHYX
Will CIHYX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
The People Pillar is our evaluation of the CIHYX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.
Parent Pillar
The Parent Pillar is our rating of CIHYX’s parent organization’s priorities and whether they’re in line with investors’ interests.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 6.8
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Usd | 8.12 | 2M | Cash and Equivalents |
Ford Motor Company 6.1% | 0.96 | 219,147 | Corporate |
Organon & Co 5.125% | 0.87 | 198,872 | Corporate |
Bausch Health Companies Inc 2025 Term Loan B | 0.75 | 171,413 | Corporate |
EchoStar Corp. 10.75% | 0.69 | 158,490 | Corporate |
AerCap Ireland Capital Designated Activity Co. / AerCap Global Aviation Tru | 0.67 | 152,774 | Corporate |
Amneal Pharmaceuticals Llc 2026 Repriced Term Loan | 0.61 | 140,184 | Corporate |
Par Petroleum Llc 2025 Term Loan B | 0.60 | 136,654 | Corporate |
CSC Holdings, LLC 4.5% | 0.57 | 129,901 | Corporate |
Altice France Sa 2025 Ext Term Loan B14 | 0.55 | 126,365 | Corporate |
United States